|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent GRPH insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why GRPH insider buys are important for investors to follow.
Date | Insider | Price | Amount |
4-11-2022 Insider Buy |
Phil Gutry CHIEF BUSINESS OFFICER |
$4.01
CAGR »
|
$20,050.00 5,000 shares |
4-12-2022 Insider Buy |
Samsara BioCapital, L.P. >10% Owner |
$4.08
CAGR »
|
$1,731,068.48 424,464 shares |
1-24-2022 Insider Buy |
Samsara BioCapital, L.P. >10% Owner |
$8.94
CAGR »
|
$1,099,100.00 123,000 shares |
1-20-2022 Insider Buy |
Samsara BioCapital, L.P. >10% Owner |
$9.10
CAGR »
|
$888,677.20 97,670 shares |
12-15-2021 Insider Buy |
Samsara BioCapital, L.P. >10% Owner |
$10.19
CAGR »
|
$227,532.51 22,329 shares |
11-22-2021 Insider Buy |
Samsara BioCapital, L.P. >10% Owner |
$10.15
CAGR »
|
$2,047,102.75 201,685 shares |
10-15-2021 Insider Buy |
Samsara BioCapital, L.P. >10% Owner |
$13.14
CAGR »
|
$667,665.00 50,800 shares |
10-8-2021 Insider Buy |
Samsara BioCapital, L.P. >10% Owner |
$13.53
CAGR »
|
$1,968,972.99 145,496 shares |
6-29-2021 Insider Buy |
Samsara BioCapital, L.P. >10% Owner |
$17.00
CAGR »
|
$8,500,000.00 500,000 shares |
6-29-2021 Insider Buy |
Versant Venture Capital VI, L.P. >10% Owner |
$17.00
CAGR »
|
$3,060,000.00 180,000 shares |
6-29-2021 Insider Buy |
Davis Jerel Director and >10% Owner |
$17.00
CAGR »
|
$3,060,000.00 180,000 shares |
6-29-2021 Insider Buy |
Smital Shah Director |
$17.00
CAGR »
|
$99,994.00 5,882 shares |
Also See: Institutional Holders of GRPH
Also See: SEC filings
Below we present the annualized performance delivered by GRPH stock since 4-11-2022 (the date of the most recent
insider purchase). The performance of the investment from the time GRPH insider buying occurred is the ultimate
test of whether insiders were right about GRPH being a good buy.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
04/12/2022 |
|
End date: |
03/21/2024 |
|
Start price/share: |
$4.04 |
|
End price/share: |
$3.18 |
|
Starting shares: |
2,475.25 |
|
Ending shares: |
3,238.57 |
|
Dividends reinvested/share: |
$1.03 |
|
Total return: |
2.99% |
|
Average Annual Total Return: |
1.53% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$10,299.34 |
|
Years: |
1.94 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/12/2022 |
|
End date: |
03/21/2024 |
|
Start price/share: |
$4.04 |
|
End price/share: |
$3.18 |
|
Dividends collected/share: |
$1.03 |
|
Total return: |
4.21% |
|
Average Annual Total Return: |
2.14% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$10,419.88 |
|
Years: |
1.94 |
|
GRPH Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent GRPH insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding GRPH
|
|